Your browser doesn't support javascript.
loading
Safety and efficacy of achieving very low low-density lipoprotein cholesterol levels with rosuvastatin 40 mg daily (from the ASTEROID Study).
Wiviott, Stephen D; Mohanavelu, Satishkumar; Raichlen, Joel S; Cain, Valerie A; Nissen, Steven E; Libby, Peter.
Affiliation
  • Wiviott SD; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. swiviott@partners.org
Am J Cardiol ; 104(1): 29-35, 2009 Jul 01.
Article in En | MEDLINE | ID: mdl-19576317
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Sulfonamides / Coronary Artery Disease / Cholesterol, VLDL / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Fluorobenzenes / Hyperlipidemias Type of study: Guideline / Observational_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Cardiol Year: 2009 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Sulfonamides / Coronary Artery Disease / Cholesterol, VLDL / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Fluorobenzenes / Hyperlipidemias Type of study: Guideline / Observational_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Cardiol Year: 2009 Document type: Article Affiliation country: United States Country of publication: United States